Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
611
NCT02017340
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Phase: Phase 3
Role: Collaborator
Start: Apr 24, 2013
Completion: Dec 16, 2016
NCT02763163
Examination of the Link Between Sun Exposure Routine and Bacteria Population of the Skin
Phase: N/A
Start: May 31, 2016
Completion: Sep 30, 2016